ESR1 and breast cancer: A number of molecular mechanisms have been reported on ER down-regulation and loss in breast cancer: ER gene mutation, ER gene heterozygosity loss, altered transcriptional regulation of ER promoter, ER mRNA destabilization, ER mRNA alternative splicing, ER proteasome degradation, hyperactive GFR/MAPK signaling and epigenetic regulation.